Kristen Focht, MBA | Psychiatrist.com

Original Research

Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

October 28, 2014

Anita H. Clayton, Karen A. Tourian, Kristen Focht, et al

Article

Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

October 15, 2013

Anita H. Clayton, Susan G. Kornstein, Boadie W. Dunlop, et al

Original Research

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression: Implications for Personalized Medicine

March 13, 2013

Sheldon H. Preskorn, Cecelia P. Kane, Kasia Lobello, et al